CareDx (CDNA) Competitors

RadNet (NASDAQ:RDNT) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation.

Is RDNT or CDNA more profitable?

RadNet has a net margin of -0.25% compared to CareDx's net margin of -45.90%. RadNet's return on equity of 4.29% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.25%	4.29%	1.45%
CareDx	-45.90%	-53.70%	-30.42%

Do institutionals and insiders believe in RDNT or CDNA?

77.9% of RadNet shares are owned by institutional investors. 5.1% of RadNet shares are owned by company insiders. Comparatively, 4.9% of CareDx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Do analysts prefer RDNT or CDNA?

RadNet presently has a consensus price target of $69.75, suggesting a potential upside of 33.16%. CareDx has a consensus price target of $30.33, suggesting a potential upside of 79.70%. Given CareDx's higher probable upside, analysts clearly believe CareDx is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.40
CareDx	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57

Does the MarketBeat Community favor RDNT or CDNA?

CareDx received 87 more outperform votes than RadNet when rated by MarketBeat users. However, 66.29% of users gave RadNet an outperform vote while only 65.92% of users gave CareDx an outperform vote.

Company	Underperform	Outperform
RadNet	Outperform Votes 356 66.29%	Underperform Votes 181 33.71%
CareDx	Outperform Votes 443 65.92%	Underperform Votes 229 34.08%

Which has better valuation and earnings, RDNT or CDNA?

RadNet has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$1.83B	2.12	$3.04M	$0.03	1,746.00
CareDx	$333.79M	2.80	-$190.28M	$1.02	16.55

Does the media prefer RDNT or CDNA?

In the previous week, RadNet had 3 more articles in the media than CareDx. MarketBeat recorded 14 mentions for RadNet and 11 mentions for CareDx. RadNet's average media sentiment score of 1.37 beat CareDx's score of 1.17 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	10 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CareDx	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, RDNT or CDNA?

RadNet has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500. Comparatively, CareDx has a beta of 2.18, suggesting that its share price is 118% more volatile than the S&P 500.

Summary

RadNet beats CareDx on 12 of the 19 factors compared between the two stocks.